iShares Global Healthcare ETF (NYSEARCA:IXJ) Reaches New 12-Month High – Should You Buy?

iShares Global Healthcare ETF (NYSEARCA:IXJ) shares reached a new 52-week high on Thursday. The company traded as high as $107.92 and last traded at $107.6550, with a volume of 69,415 shares. The stock had previously closed at $105.06.

iShares Global Healthcare ETF Stock Down 0.3%

The company’s fifty day moving average is $103.67 and its two-hundred day moving average is $98.62. The firm has a market capitalization of $4.52 billion, a price-to-earnings ratio of 21.58 and a beta of 0.55.

Institutional Trading of iShares Global Healthcare ETF

Institutional investors and hedge funds have recently made changes to their positions in the business. Hamilton Wealth LLC lifted its stake in shares of iShares Global Healthcare ETF by 93.4% in the 4th quarter. Hamilton Wealth LLC now owns 95,799 shares of the company’s stock valued at $9,331,000 after purchasing an additional 46,269 shares during the period. Envestnet Asset Management Inc. grew its stake in shares of iShares Global Healthcare ETF by 45.2% during the second quarter. Envestnet Asset Management Inc. now owns 148,494 shares of the company’s stock worth $14,609,000 after purchasing an additional 46,194 shares during the period. Meridian Investment Counsel Inc. acquired a new stake in shares of iShares Global Healthcare ETF during the third quarter worth $2,415,000. Balefire LLC acquired a new stake in shares of iShares Global Healthcare ETF during the second quarter worth $1,680,000. Finally, Vontobel Holding Ltd. bought a new stake in iShares Global Healthcare ETF in the third quarter valued at about $1,705,000.

About iShares Global Healthcare ETF

iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.